Lateral flow assay (LFA) offers simple, low-cost, rapid, point-of-care detection and quantification of analytes in complex mixtures, within 5-30 min. Low development costs and ease of operation of LFAs are results into expansion of its application in biomedicine, agriculture, veterinary, food safety and drug development. High prevalence of infectious disease and increasing adoption of lateral flow assay device in hospitals, physician’s clinics and clinical laboratories for the qualitative and quantitative detection of specific antigen and antibodies is expected to drive growth of lateral flow assay market over the forecast period. For instance, according to the World health Organization (WHO) January 2018 data findings, tuberculosis(TB) was reported to be one of the top 10 causes of death, in 2016 worldwide. Furthermore, in 2016, an estimated 1 million children were suffer from tuberculosis and 2, 50,000 children died of TB (including children with HIV associated TB).
Market Dynamics
The global lateral flow assay market is projected to witness significant growth over the forecast period, owing to growing adoption of lateral flow assay in various applications including clinical diagnostics, drug development, quality testing, veterinary diagnostic, food and environmental testing, micronutrient monitoring, diagnosing invasive pulmonary aspergillosis, qualitative and quantitative detection of specific antigens and antibodies, and gene amplification. For instance, according to the American Pharmaceutical Association (APhA) Academy of Student Pharmacists: Resolutions Committee-2015 report, 8,856 community pharmacies have a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver, which enables pharmacists to perform POC tests such as glucose measurement and other POC testing. Moreover, increasing adaptation of point-of-care testing in clinical diagnosis and integration of POC testing in lateral flow assay tests are expected to drive growth of the lateral flow assay market over the forecasted period. However, variance or inconsistency results by lateral flow assay would lead to lower adoption of the technology, which in turn would hinder the growth of lateral flow assay market.
Key features of the study:
- This report provides in-depth analysis of the lateral flow assay market and its market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global lateral flow assay market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
- Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Inc., Qiagen N.V., Becton, Dickinson and Company, Diagnostic Consulting Network, Inc., Tetracore, Inc., Humasis Co. Ltd., and F. Hoffmann-La Roche AG.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
- The global lateral flow assay market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for lateral flow assay kits and reagents, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
- Global Lateral Flow Assay Market, By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- Global Lateral Flow Assay Market, By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- Global Lateral Flow Assay Market, By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- Global Lateral Flow Assay Market, By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Global Lateral Flow Assay Market, By Region:
- North America
- By Country
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Asia-Pacific
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Africa
- By Country:
- North Africa
- Central Africa
- South Africa
- By Product Type:
- Kits and Reagents
- Lateral Flow Readers
- By Technique:
- Competitive Assay
- Multiplex Detection Assay
- Sandwich Assay
- By Application:
- Veterinary Diagnostics
- Drug Development and Quality Testing
- Clinical Testing
- Food Safety and Environmental Testing
- By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Home Care Settings
- Company Profiles
- Bio-Rad Laboratories, Inc. *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Thermo Fisher Scientific Inc.
- Siemens Healthineers, Inc.
- Qiagen N.V.
- Becton, Dickinson and Company
- Diagnostic Consulting Network, Inc.
- Tetracore, Inc.
- Humasis Co. Ltd.
- Hoffmann-La Roche AG
“*” marked represents similar segmentation in other categories in the respective section.